Sunday, 18 April 2010

Cambridge University Drug Hope for MS

Suggested by one our our members as a post:

CambridgeUniversity — 29 September 2009 — A drug which was developed in Cambridge and initially designed to treat a form of leukaemia has also proven effective against combating the debilitating neurological disease multiple sclerosis (MS). 
The study, led by researchers from the University of Cambridge, has found that alemtuzumab not only stops MS from advancing in patients with early stage active relapsing-remitting multiple sclerosis (RRMS) but may also restore lost function caused by the disease. The findings were published today in the New England Journal of Medicine.
 
Watch on you tube here